Skip to main content

Qiagen

QIAGEN N.V. is a Netherlands-based provider of sample preparation and assay technologies for molecular diagnostics, applied testing, and academic research. The company supplies integrated workflows that enable customers to extract and analyze DNA, RNA, and proteins from biological samples. Its principal products encompass proprietary reagent kits, automated laboratory instrumentation, and bioinformatics software utilized in clinical testing and drug discovery. Revenue is driven primarily through consumable-based sales of reagent kits alongside instrument placements to molecular laboratories. The primary end markets comprise clinical healthcare laboratories, pharmaceutical research organizations, and academic institutions worldwide. As an established participant in molecular biology and testing, the enterprise plays a key role in diagnostic solutions. Headquartered in Venlo, Netherlands, QIAGEN N.V. is publicly listed on the Frankfurt Stock Exchange and the New York Stock Exchange.

38 of the funds FundTelligence covers report a position in Qiagen.

Legal name
QIAGEN
Sector
Health Care
Country
Netherlands
Funds holding it
38
Exposure themes
Genomics & Profiling, Genomic Tools, Precision Medicine & Genomics

Funds holding Qiagen

Showing the 8 largest of 38 funds holding it.

Loading...